Apoptosis: basic mechanisms and implications for cardiovascular disease.
暂无分享,去创建一个
[1] S. Chen,et al. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Sheridan,et al. Identification of a ligand for the death-domain-containing receptor Apo3 , 1998, Current Biology.
[3] J. Savill. Apoptosis: Phagocytic docking without shocking , 1998, Nature.
[4] D. Goeddel,et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.
[5] T. Yue,et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. , 1998, Circulation research.
[6] T. Libermann,et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] Jennifer L Hall,et al. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease , 1998, Nature Medicine.
[8] K. Maehara,et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. , 1998, Circulation.
[9] J Ross,et al. Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.
[10] S. Nagata,et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.
[11] S. Nagata,et al. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 1998, Nature.
[12] L. Scorrano,et al. The mitochondrial permeability transition , 2022, BioFactors.
[13] V. Gil. [Hibernating myocardium. An incomplete adaptation to ischemia]. , 1998, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[14] L. Truong,et al. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. , 1997, The Journal of clinical investigation.
[15] John Calvin Reed,et al. The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.
[16] M. V. Heiden,et al. Bcl-xL Regulates the Membrane Potential and Volume Homeostasis of Mitochondria , 1997, Cell.
[17] R. Dietz,et al. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. , 1997, Circulation.
[18] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[19] D. Goeddel,et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. , 1997, Immunity.
[20] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[21] Q. Li,et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. , 1997, The Journal of clinical investigation.
[22] Jay X. Tang,et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. , 1997, Science.
[23] P. Libby,et al. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[24] T. Littlewood,et al. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. , 1997, Circulation research.
[25] P. Libby,et al. The unstable atheroma. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[26] A. Koretsky,et al. Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .
[27] Y. Zou,et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. , 1997, The Journal of clinical investigation.
[28] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[29] M. Malim,et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Kitsis,et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. , 1997, The Journal of clinical investigation.
[31] L. Kirshenbaum,et al. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. , 1997, Circulation.
[32] Henning Walczak,et al. TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL , 1997, The EMBO journal.
[33] G. Núñez,et al. Interaction and Regulation of the Caenorhabditis elegans Death Protease CED-3 by CED-4 and CED-9* , 1997, The Journal of Biological Chemistry.
[34] W I Wood,et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.
[35] Y. Goltsev,et al. CASH, a Novel Caspase Homologue with Death Effector Domains* , 1997, The Journal of Biological Chemistry.
[36] Xiaodong Wang,et al. Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.
[37] N. Thornberry,et al. Caspases: killer proteases. , 1997, Trends in biochemical sciences.
[38] W. MacLellan,et al. Death by design. Programmed cell death in cardiovascular biology and disease. , 1997, Circulation research.
[39] Seamus J. Martin,et al. Cytochrome c activation of CPP32‐like proteolysis plays a critical role in a Xenopus cell‐free apoptosis system , 1997, The EMBO journal.
[40] D. Altieri,et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.
[41] S. Srinivasula,et al. FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.
[42] M. Horiuchi,et al. Angiotensin Type 2 Receptor Dephosphorylates Bcl-2 by Activating Mitogen-activated Protein Kinase Phosphatase-1 and Induces Apoptosis* , 1997, The Journal of Biological Chemistry.
[43] G. Salvesen,et al. The Regulation of Anoikis: MEKK-1 Activation Requires Cleavage by Caspases , 1997, Cell.
[44] N. Thornberry,et al. A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.
[45] A. Tedgui,et al. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. , 1997, Circulation.
[46] M. Perricaudet,et al. Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. , 1997, Circulation.
[47] R. Gentz,et al. I-FLICE, a Novel Inhibitor of Tumor Necrosis Factor Receptor-1- and CD-95-induced Apoptosis* , 1997, The Journal of Biological Chemistry.
[48] Margot Thome,et al. Inhibition of death receptor signals by cellular FLIP , 1997, Nature.
[49] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.
[50] G.T. Williams,et al. Caspase activity is required for commitment to Fas‐mediated apoptosis , 1997, The EMBO journal.
[51] Howard Y. Chang,et al. Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis , 1997, Cell.
[52] John Calvin Reed. Double identity for proteins of the Bcl-2 family , 1997, Nature.
[53] M. Bennett,et al. Thrombin generation by apoptotic vascular smooth muscle cells. , 1997, Blood.
[54] C. Kurschner,et al. Modulation of Cell Death in Yeast by the Bcl-2 Family of Proteins* , 1997, The Journal of Biological Chemistry.
[55] A. Porter,et al. Death substrates come alive , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.
[56] W. Schaper,et al. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. , 1997, Atherosclerosis.
[57] E. Lakatta,et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. , 1997, The Journal of clinical investigation.
[58] W. May,et al. Bcl-2 Phosphorylation Required for Anti-apoptosis Function* , 1997, The Journal of Biological Chemistry.
[59] M. Takemura,et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. , 1997, Journal of the American College of Cardiology.
[60] Xiaodong Wang,et al. DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.
[61] C A Beltrami,et al. Apoptosis in the failing human heart. , 1997, The New England journal of medicine.
[62] Arul M. Chinnaiyan,et al. The Receptor for the Cytotoxic Ligand TRAIL , 1997, Science.
[63] J. Tschopp,et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.
[64] N. Inohara,et al. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival‐promoting proteins Bcl‐2 and Bcl‐XL , 1997, The EMBO journal.
[65] A. Zeiher,et al. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. , 1997, Circulation.
[66] P. Libby,et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[67] P. Anversa,et al. Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro , 1997 .
[68] K. Chien,et al. Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway , 1997, The Journal of Biological Chemistry.
[69] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.
[70] A. Chinnaiyan,et al. Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death , 1997, Science.
[71] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[72] Lewis C Cantley,et al. PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.
[73] E. Yeh,et al. Life and death in the cardiovascular system. , 1997, Circulation.
[74] K Walsh,et al. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. , 1997, Circulation.
[75] J. Bertin,et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[76] M. Nehls,et al. Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.
[77] A. Schroit,et al. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.
[78] S. Srinivasula,et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. , 1997, Cancer research.
[79] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[80] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[81] T. Mak,et al. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. , 1997, Circulation.
[82] A. Nègre-Salvayre,et al. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[83] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[84] Andy J. Minn,et al. Bcl-xL forms an ion channel in synthetic lipid membranes , 1997, Nature.
[85] T. Mak,et al. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3 , 1997, Nature.
[86] A. Saraste,et al. Apoptosis in human acute myocardial infarction. , 1997, Circulation.
[87] D. Leroith,et al. Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways* , 1997, The Journal of Biological Chemistry.
[88] Minoru Takagi,et al. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.
[89] Vishva M. Dixit,et al. RAIDD is a new 'death' adaptor molecule , 1997, Nature.
[90] N. Bishopric,et al. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. , 1996, The Journal of biological chemistry.
[91] P. Anversa,et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. , 1997, Journal of molecular and cellular cardiology.
[92] Y. Geng. Regulation of programmed cell death or apoptosis in atherosclerosis. , 1997, Heart and vessels.
[93] D. Zechner,et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. , 1996, The Journal of clinical investigation.
[94] R. Davis,et al. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. , 1996, The Journal of biological chemistry.
[95] S. Srinivasula,et al. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[96] Y. Sofer-Levi,et al. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. , 1996, Oncogene.
[97] R. Testi,et al. Sphingomyelin breakdown and cell fate. , 1996, Trends in biochemical sciences.
[98] K. Sullivan,et al. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. , 1996, The New England journal of medicine.
[99] D. Goeddel,et al. A death-domain-containing receptor that mediates apoptosis , 1996, Nature.
[100] Keisuke Kuida,et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.
[101] C. Milliman,et al. BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.
[102] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[103] John Calvin Reed,et al. Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria , 1996, Cell.
[104] A. Chinnaiyan,et al. Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95 , 1996, Science.
[105] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[106] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[107] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[108] H. Fliss,et al. Apoptosis in ischemic and reperfused rat myocardium. , 1996, Circulation research.
[109] M. Abdellatif,et al. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. , 1996, Developmental biology.
[110] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[111] Junying Yuan,et al. Human ICE/CED-3 Protease Nomenclature , 1996, Cell.
[112] R. Frank,et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. , 1996, The New England journal of medicine.
[113] R. Virmani,et al. Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.
[114] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[115] Y. Hayakawa,et al. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. , 1996, Circulation.
[116] R. Michler,et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. , 1996, Circulation.
[117] S. Nagata,et al. Apoptosis: Telling cells their time is up , 1996, Current Biology.
[118] G. Kroemer,et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.
[119] P. Anversa,et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. , 1996, Journal of molecular and cellular cardiology.
[120] S. Hsu,et al. In situ apoptosis assay for the detection of early acute myocardial infarction. , 1996, The American journal of pathology.
[121] C. Prives,et al. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis , 1996, Molecular and cellular biology.
[122] K. Vousden,et al. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function , 1996, Molecular and cellular biology.
[123] N. Copeland,et al. bcl-w, a novel member of the bcl-2 family, promotes cell survival. , 1996, Oncogene.
[124] Y. Lazebnik,et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[125] B. Björkerud,et al. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.
[126] Seamus J. Martin,et al. Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis , 1996, Cell.
[127] S. Srinivasula,et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[128] A. Chinnaiyan,et al. The CED-3/ICE-like Protease Mch2 Is Activated during Apoptosis and Cleaves the Death Substrate Lamin A* , 1996, The Journal of Biological Chemistry.
[129] S. Korsmeyer,et al. Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors* , 1996, The Journal of Biological Chemistry.
[130] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.
[131] L. Gaboury,et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. , 1996, The Journal of clinical investigation.
[132] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.
[133] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[134] J. Avruch,et al. Stress-activated protein kinases in cardiovascular disease. , 1996, Circulation research.
[135] M. Raff,et al. Constitutive expression of the machinery for programmed cell death , 1996, The Journal of cell biology.
[136] S. Marsters,et al. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.
[137] R. Meadows,et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.
[138] D. Vaux,et al. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[139] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[140] L. Zon,et al. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat , 1996, Current Biology.
[141] S. Nagata,et al. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.
[142] D. Goeddel,et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.
[143] T. N. James,et al. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. , 1996, Circulation.
[144] G. Kroemer,et al. Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.
[145] John Calvin Reed,et al. Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2 (*) , 1996, The Journal of Biological Chemistry.
[146] L. Zon,et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis , 1996, Nature.
[147] A. Chinnaiyan,et al. Molecular Ordering of the Cell Death Pathway , 1996, The Journal of Biological Chemistry.
[148] H. Horvitz,et al. Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. , 1996, Genes & development.
[149] D. Mann,et al. Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .
[150] John Calvin Reed,et al. A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. , 1996, Blood.
[151] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[152] S. Hosoda,et al. Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. , 1996, Journal of molecular and cellular cardiology.
[153] P. Libby,et al. Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β , 1996 .
[154] D. Baltimore,et al. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. , 1996, Science.
[155] C. Y. Wang,et al. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. , 1996, Science.
[156] D. Baltimore,et al. NF-kappa B: ten years after. , 1996, Cell.
[157] D. Green,et al. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. , 1996, Science.
[158] M. Lesch,et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. , 1996, The American journal of pathology.
[159] John Calvin Reed,et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[160] D. Mann,et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. , 1996, Circulation.
[161] P. Libby,et al. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[162] Mike Rothe,et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins , 1995, Cell.
[163] P. Anversa,et al. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[164] D. Gibson,et al. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. , 1995, Circulation research.
[165] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[166] J. M. Boyd,et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. , 1995, Oncogene.
[167] E. Sonnenblick,et al. Stretch-induced programmed myocyte cell death. , 1995, The Journal of clinical investigation.
[168] T. Chittenden,et al. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. , 1995, The EMBO journal.
[169] C H Davies,et al. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. , 1995, Circulation.
[170] D. Green,et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.
[171] P. Anversa,et al. The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. , 1995, Circulation.
[172] S. Korsmeyer,et al. Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death , 1995, Science.
[173] J. Frostegård,et al. Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-gamma production in lymphocytes from healthy individuals. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[174] P. Sugden,et al. Intracellular signalling through protein kinases in the heart. , 1995, Cardiovascular research.
[175] M. Lenardo,et al. Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.
[176] Y. Lazebnik,et al. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[177] O. Febo,et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.
[178] D. Mann,et al. Expression and functional significance of tumor necrosis factor receptors in human myocardium. , 1995, Circulation.
[179] H. Preisler,et al. Two in situ labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. , 1995, Anticancer research.
[180] Seamus J. Martin,et al. Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.
[181] P. Libby,et al. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.
[182] M. Leon,et al. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.
[183] G. Evan,et al. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. , 1995, Circulation research.
[184] D. Mann,et al. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. , 1995, The Journal of clinical investigation.
[185] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[186] P. Petit,et al. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis , 1995, The Journal of cell biology.
[187] H. Ikeda,et al. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. , 1995, The American journal of pathology.
[188] J. Isner,et al. Apoptosis in human atherosclerosis and restenosis. , 1995, Circulation.
[189] J. Martinou,et al. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K , 1995, Nature.
[190] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[191] P. Leder,et al. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.
[192] D. Goeddel,et al. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.
[193] G. Evan,et al. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.
[194] A. Desmoulière,et al. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. , 1995, The American journal of pathology.
[195] L. Rubin,et al. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death , 1995, Neuron.
[196] G. Kroemer,et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo , 1995, The Journal of experimental medicine.
[197] M. Raff,et al. Programmed cell death and Bcl-2 protection in very low oxygen , 1995, Nature.
[198] Matthew J. Brauer,et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak , 1995, Nature.
[199] G. Evan,et al. Induction of apoptosis by the Bcl-2 homologue Bak , 1995, Nature.
[200] L. Kirshenbaum,et al. Adenovirus E1A Represses Cardiac Gene Transcription and Reactivates DNA Synthesis in Ventricular Myocytes, via Alternative Pocket Protein- and p300-binding Domains (*) , 1995, The Journal of Biological Chemistry.
[201] G. Cooper,et al. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.
[202] M. Su,et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.
[203] al. et,et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice , 1995, Science.
[204] P. Olive,et al. The comet assay: a comprehensive review. , 1995, Mutation research.
[205] S. Korsmeyer,et al. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.
[206] T. Noda,et al. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. , 1995, Cancer research.
[207] T. Crawford,et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy , 1995, Cell.
[208] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[209] D. Goeddel,et al. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. , 1995, Cell.
[210] G. Majno,et al. Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.
[211] D. Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. , 1995, Nature.
[212] S. Nagata,et al. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver , 1995, Nature Genetics.
[213] W. Kaelin,et al. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[214] R. Kloner,et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. , 1994, The Journal of clinical investigation.
[215] C. Haslett,et al. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. , 1994, Journal of immunology.
[216] J. Bultinck,et al. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts , 1994, Histopathology.
[217] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[218] Y. Lazebnik,et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE , 1994, Nature.
[219] F. Marumo,et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. , 1994, Circulation research.
[220] H. Hartung,et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[221] J. Mankovich,et al. Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer , 1994, Cell.
[222] T. N. James,et al. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. , 1994, Transactions of the American Clinical and Climatological Association.
[223] Z. Oltvai,et al. Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. , 1994, The Journal of biological chemistry.
[224] D. Loh,et al. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[225] M. Raff,et al. Programmed cell death and Bcl‐2 protection in the absence of a nucleus. , 1994, The EMBO journal.
[226] M. Birnbaum,et al. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs , 1994, Journal of virology.
[227] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[228] C. Hartley,et al. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. , 1994, The American journal of cardiology.
[229] G. Evan,et al. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. , 1994, Circulation research.
[230] M. Murcko,et al. Structure and mechanism of interleukin-1 beta converting enzyme. , 1994, Nature.
[231] Takashi Suda,et al. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.
[232] Shai Shaham,et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.
[233] S. Korsmeyer,et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.
[234] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[235] V. Stewart,et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. , 1993, Science.
[236] L. Tartaglia,et al. A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.
[237] J. Hickman,et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. , 1993, The EMBO journal.
[238] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[239] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[240] S. Nagata,et al. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.
[241] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[242] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[243] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[244] X. M. Sun,et al. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. , 1993, The Journal of biological chemistry.
[245] John Calvin Reed,et al. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA , 1993, Nature.
[246] J. H. Dierendonck,et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[247] I. Weissman,et al. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. , 1992, Science.
[248] C. Haslett,et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. , 1992, Journal of immunology.
[249] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[250] S. Korsmeyer,et al. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[251] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[252] P. Allen,et al. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. , 1992, Circulation research.
[253] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[254] N. Copeland,et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.
[255] A. Eastman,et al. The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? , 1992, Cancer investigation.
[256] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[257] K. Weber,et al. Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.
[258] P. Libby,et al. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[259] H. Tabuchi,et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor , 1990, Cell.
[260] N. Hogg,et al. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis , 1990, Nature.
[261] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[262] J. Sklar,et al. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.
[263] H. Horvitz,et al. Genetic control of programmed cell death in the nematode C. elegans , 1986, Cell.
[264] A. Wyllie. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.
[265] Dr. méd. Tomas Pexieder. Cell death in the morphogenesis and teratogenesis of the heart , 1975, Ergebnisse der Anatomie und Entwicklungsgeschichte Advances in Anatomy, Embryology and Cell Biology Revues d’anatomie et de morphologie expérimentale.
[266] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[267] Ian Aird,et al. Response to Injury , 1952 .